Vaccination against the human cytomegalovirus

The human cytomegalovirus (HCMV) is the most important infectious cause of congenital abnormalities and also of infectious complications of transplantation. The biology of the infection is complex and acquired immunity does not always prevent reinfection. Nevertheless, vaccine development is far adv...

Descripción completa

Detalles Bibliográficos
Autores principales: Plotkin, Stanley A., Boppana, Suresh B.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Science 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6892274/
https://www.ncbi.nlm.nih.gov/pubmed/29622379
http://dx.doi.org/10.1016/j.vaccine.2018.02.089
_version_ 1783475999277580288
author Plotkin, Stanley A.
Boppana, Suresh B.
author_facet Plotkin, Stanley A.
Boppana, Suresh B.
author_sort Plotkin, Stanley A.
collection PubMed
description The human cytomegalovirus (HCMV) is the most important infectious cause of congenital abnormalities and also of infectious complications of transplantation. The biology of the infection is complex and acquired immunity does not always prevent reinfection. Nevertheless, vaccine development is far advanced, with numerous candidate vaccines being tested, both live and inactivated. This article summarizes the status of the candidate vaccines.
format Online
Article
Text
id pubmed-6892274
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Elsevier Science
record_format MEDLINE/PubMed
spelling pubmed-68922742019-12-16 Vaccination against the human cytomegalovirus Plotkin, Stanley A. Boppana, Suresh B. Vaccine Article The human cytomegalovirus (HCMV) is the most important infectious cause of congenital abnormalities and also of infectious complications of transplantation. The biology of the infection is complex and acquired immunity does not always prevent reinfection. Nevertheless, vaccine development is far advanced, with numerous candidate vaccines being tested, both live and inactivated. This article summarizes the status of the candidate vaccines. Elsevier Science 2019-11-28 /pmc/articles/PMC6892274/ /pubmed/29622379 http://dx.doi.org/10.1016/j.vaccine.2018.02.089 Text en © 2018 The Authors. Published by Elsevier Ltd. http://creativecommons.org/licenses/by/4.0/ This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Plotkin, Stanley A.
Boppana, Suresh B.
Vaccination against the human cytomegalovirus
title Vaccination against the human cytomegalovirus
title_full Vaccination against the human cytomegalovirus
title_fullStr Vaccination against the human cytomegalovirus
title_full_unstemmed Vaccination against the human cytomegalovirus
title_short Vaccination against the human cytomegalovirus
title_sort vaccination against the human cytomegalovirus
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6892274/
https://www.ncbi.nlm.nih.gov/pubmed/29622379
http://dx.doi.org/10.1016/j.vaccine.2018.02.089
work_keys_str_mv AT plotkinstanleya vaccinationagainstthehumancytomegalovirus
AT boppanasureshb vaccinationagainstthehumancytomegalovirus

Ejemplares similares